This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Riccardo Giovaninni: Innovator in Pharmaceutical Chemistry
Introduction
Riccardo Giovaninni is a notable inventor based in Biberach an der Riss, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on compounds that target specific receptors in the brain.
Latest Patents
Giovaninni holds a patent for "Substituted pyrazine-carboxamide derivatives." This invention relates to compounds of formula I, a process for their manufacture, pharmaceutical compositions containing them, and their use in therapy. The focus of this patent is particularly on the treatment and/or prevention of conditions associated with the function of metabotropic glutamate receptor subtype 4 (mGluR4).
Career Highlights
He is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work there has allowed him to explore and develop new therapeutic options that can significantly impact patient care.
Collaborations
Throughout his career, Giovaninni has collaborated with esteemed colleagues such as Roland Pfau and Georg Dahmann. These partnerships have fostered a collaborative environment that enhances innovation and research in pharmaceutical development.
Conclusion
Riccardo Giovaninni's contributions to pharmaceutical chemistry, particularly through his patented inventions, highlight his role as a key innovator in the field. His work continues to pave the way for advancements in therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile